Fig. 1From: Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life dataKaplan–Meier estimator of patients with and without adjuvant chemotherapy. Adjuvant chemotherapy after pancreas surgery due to pancreatic ductal adenocarcinoma led to a significantly better survival (14.3 vs. 25.6 months, p = 0.001)Back to article page